Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.31Cash Ratio
VS
Market
Sector
Industry
History
$ 0.74Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information
Ticker
GTBPCompany Name
GT BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGT BIOPHARMA INC - Cash Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GTBP - Cash Ratio Historical data
| Date | Cash and Equivalents | Cash Ratio | Current Liabilities |
|---|---|---|---|
| 6/30/2025 | $ 5.32M | 2.31 | $ 2.31M |
| 3/31/2025 | $ 2.46M | 0.68 | $ 3.64M |
| 12/31/2024 | $ 4.04M | 0.69 | $ 5.9M |
| 9/30/2024 | $ 6.51M | 1.4 | $ 4.66M |
| 6/30/2024 | $ 9.25M | 2.46 | $ 3.76M |
| 3/31/2024 | $ 1.95M | 0.42 | $ 4.6M |
| 12/31/2023 | $ 1.08M | 0.16 | $ 6.63M |
| 9/30/2023 | $ 2.66M | 0.52 | $ 5.09M |
| 6/30/2023 | $ 2.78M | 0.57 | $ 4.84M |
| 3/31/2023 | $ 2.05M | 0.5 | $ 4.08M |
Key Performance Insights, Last 5 Years
- GT BIOPHARMA INC's latest trailing twelve months (TTM) Cash Ratio stands at 0.01.
- Over the past 5 years, GT BIOPHARMA INC's average Cash Ratio has been 1.8.
- The median Cash Ratio for GT BIOPHARMA INC during this period was 0.68
- GT BIOPHARMA INC reached its highest Cash Ratio over the past 5 years at 12.06.
- The lowest Cash Ratio recorded by GT BIOPHARMA INC in the same timeframe 0.01
Similar metrics to LiabilitesC:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
Definition of Cash Ratio
[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].CashnEq / LiabilitesC
(=) Cash Ratio Cash Ratio for GT BIOPHARMA INC is calculated as follows: CashnEq [ $ 362K ] / LiabilitesC [ $ 30.69M ]
(=) Cash Ratio [ 0.01 ] GTBP - Cash Ratio, Last 5 years
0.01
Minimum
Sep 30, 2020
12.06
Maximum
Jun 30, 2021
1.8
Average
0.68
Median
Cash Ratio Benchmark AnalysisMarket
The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | 0 |
| max | 2.69 |
| average | 0.62 |
| median | 0.39 |
| std | 0.63 |